Latest News about GILD
Recent news which mentions GILD
From Benzinga
From Benzinga
Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher
April 24, 2025
From Benzinga
Earnings Scheduled For April 24, 2025
April 24, 2025
From Benzinga
P/E Ratio Insights for Gilead Sciences
April 23, 2025
From Benzinga
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
April 21, 2025
From Benzinga
From Motley Fool
Time 100 Most Influential People Includes Elon Musk, Mark Zuckerberg, Alex Karp And More Public Company CEOs
April 16, 2025
From Benzinga
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Rule Breaker Investing: Essays From Yesterday, Vol. 7
April 10, 2025
From Motley Fool
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
From Benzinga
2 Top Dividend Stocks That Could Set You Up for Life
April 09, 2025
From Motley Fool
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
April 04, 2025
From Benzinga
From Benzinga
From Benzinga
A Closer Look at Gilead Sciences's Options Market Dynamics
March 27, 2025
Tickers
GILD
From Benzinga
From Benzinga
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides
March 19, 2025
From Benzinga
Gilead Presents New HIV Treatment And Cure Research Data
March 12, 2025
From Benzinga
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.